HC Wainwright & Co. Maintains Buy on Aspen Aerogels, Lowers Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Amit Dayal has maintained a Buy rating on Aspen Aerogels (NYSE:ASPN) but reduced the price target from $30 to $20. This adjustment reflects a change in valuation while still indicating a positive outlook on the stock.

January 16, 2024 | 8:59 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aspen Aerogels' price target has been lowered from $30 to $20 by HC Wainwright & Co., although the firm maintains a Buy rating on the stock.
The reduction in price target may cause some investors to adjust their valuation models, potentially leading to short-term price volatility. However, the maintenance of a Buy rating suggests that the analyst still sees long-term value in the company, which could mitigate any negative impact from the price target reduction.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100